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Telomerase is a reverse transcriptase that consists of the telomerase RNA component (TERC) and the
reverse transcriptase catalytic subunit (TERT) and specializes in the elongation of telomere ends. New
evidence suggests that beyond classical telomere maintenance, TERT also possesses telomere length-
independent functions that are executed via interaction with other binding proteins. One such re-
ported TERT-interacting proteins is mTOR, a master nutrient sensor that is upregulated in several can-
cers; however, the physiological implications of the TERT-mTOR interaction in normal cellular processes
as well as in tumorigenesis are poorly understood. Here, we report that TERT inhibits the kinase activity
of mTOR complex 1 (mTORC1) in multiple cell lines, resulting in the activation of autophagy under both
basal and amino acid-deprived conditions. Furthermore, TERT-deﬁcient cells display the inability to
properly execute the autophagy ﬂux. Functionally, TERT-induced autophagy provides a survival advan-
tage to cells in nutrient-deprived conditions. Collectively, these ﬁndings support a model in which gain of
TERT function modulates mTORC1 activity and induces autophagy, which is required for metabolic
rewiring to scavenge the nutrients necessary for fueling cancer cell growth in challenging tumor
microenvironments.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Macroautophagy (commonly referred to as autophagy) is the
delivery machinery for cytosolic cargo and employs the lysosome
double membrane for recycling purposes [1]. This “housekeeping”
function of autophagy is essential for maintaining cellular ho-
meostasis and cell survival during nutrient stress [2]. The
mammalian target of rapamycin complex 1 (mTORC1) is a well-
known negative regulator of autophagy [3]. This complex is
mainly comprised of mTOR, raptor, and G protein b-subunit-likese; DMEM, Dulbecco's Modi-
tion; ER, endoplasmic reticu-
, hepatocellular carcinoma;
t chain 3; MEF, mouse em-
pamycin complex 1; MTT, 3-
romide tetrazolium; PP2A,
anscriptase; ULK, unc 51-like
ry, College of Life Science and
ublic of Korea.
r Inc. This is an open access articleprotein (GbL) andworks as a signaling hub for integrating upstream
nutrient cues for the regulation of autophagy processes [4]. Since
this complex acts as the central switch for processing nutrient
signaling in the regulation of autophagy or biosynthetic pathways
[5], understanding how the molecular components of this complex
interact with other molecules and how the dynamics of these in-
teractions are altered during nutrient stress is important for un-
derstanding metabolic disorders as well as cancers [6].
The kinase activity of mTORC1 is modulated according to the
nutrient cues of the cell. Amino acids activate mTORC1, and leucine
is one of the strongest positive regulators of this complex [7].
Similarly, amino acid starvation induces a robust autophagic
response, compared to the response induced by pharmacological
inhibition of mTORC1 [8]. Moreover, protein phosphatase 2a (PP2a)
has recently been identiﬁed as an inducer of the unc 51-like kinase
1 ULK1 complex, consequently activating autophagy under condi-
tions of amino acid deprivation [8]. Starvation is known to activate
AMP-activated protein kinase (AMPK) signaling [9] by decreasing
the activity of Rag-GTPases, which are components of mTORC1 [10].
Similarly, leucine inhibits Sestrin 1/2, relieving mTORC1 inhibition
under these conditions [11].under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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cancers [12]. While optimally activated mTORC1 provides survival
and proliferation advantages to cancer cells [13], mTORC1 hyper-
activation is detrimental for tumorigenesis due to the consequent
increased endoplasmic reticulum (ER) stress and apoptosis [14].
Hypoxia and nutrient deprivation in the tumor microenvironment
also contribute to ER stress, which acts as a limiting factor for the
growth of tumors [13,15]; however, the mechanism by which
cancer cells ﬁne tune mTORC1 activity to support their growth
while simultaneously avoiding detrimental hyperactivation of
mTORC1 remains unclear.
TERT is a ribonucleoprotein DNA polymerase complex that
functions to maintain telomere length [16]. The enzymatic activity
of telomerase is not detected in normal somatic cells but is present
in stem, embryonic, highly proliferative adult, and cancer cells [17].
It is speculated that cancer cells maintain a higher level of TERT
expression to enable the cells to tackle a harsh tumor microenvi-
ronment that is deprived of sufﬁcient oxygen and nutrients [18]. As
TERT not only plays a role in cell survival but also in glycolysis [19],
increasing evidence suggests that gain of TERT function in cancer
cells facilitates energy metabolism rewiring to gain a selective
advantage to fuel cancer growth [20]; however, how TERT facili-
tates nutrient scavenging in the metabolically challenged tumor
microenvironment and the speciﬁc molecular pathways involved in
this process are poorly understood.
Based on a previous report describing TERT-mediated auto-
phagy induction in mice after ischemia reperfusion [21], we
investigated the role of TERT in autophagy under both basal and
amino acid deprivation conditions. Our results demonstrate that
TERT inhibits the mTORC1 kinase activity, resulting in activation of
autophagy that is functionally important for cell survival under
conditions of nutrient deprivation. Since TERT and mTORC1 gain of
function has been observed in several cancers, we propose a model
in which TERT optimally modulates mTORC1 activity in order to
activate autophagy, which is important for generating essential
nutrients in the metabolically challenged tumor
microenvironment.
2. Materials and methods
2.1. Reagents and constructs
Western blotting was performed using the antibodies to the
following proteins: b-actin (Santa Cruz, sc-47778), TERT (Santa
Cruz, 7214), p70S6K (Cell Signaling, # 9202), p-p70S6K (Cell
Signaling, #9205), microtubule-associated protein 1 light chain 3B
(LC3B) (Sigma-Aldrich, L7543), and Flag (Sigma-Aldrich, F1804).
Chemicals used in this study include Earle's balanced salt solution
(EBSS; Thermo Fisher Scientiﬁc, 24010), 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide tetrazolium (MTT; Sigma-
Aldrich, M5655), chloroquine (Sigma-Aldrich, C6628), and DAPI
(Sigma-Aldrich, D9542).
We generated mRFP-hTERT and 3Flag-hTERT expression plas-
mids by sub-cloning. EGFP-LC3 was purchased from Addgene
(#11546). Lentivirus packaging (psPAX2, #12260) and envelope
(pMD2.G, #12259) vectors were purchased from Addgene. TERT
shRNA transfer plasmids were purchased from Sigma-Aldrich.
2.2. Preparation of murine embryonic ﬁbroblasts (MEFs) from Tert
transgenic and knockout mice
Generation of Tert transgenic (Tert-Tg) and Tert knockout (Tert-
KO) mice and preparation of MEFs from these mice have been re-
ported previously [22]. PCR primers for the genotyping of MEFs are
provided in Supplementary Tables T1 and T2.2.3. Cell culture and transfection
All cell lines and MEFs were cultured in high-glucose Dulbecco's
modiﬁed Eagle's medium (DMEM) containing 10% FBS and 100
units/mL penicillin-streptomycin. Cells were maintained at 37 C in
a humidiﬁed chamber with 5% CO2 [23]. Cells were transfected
using Lipofectamine 2000 according to the manufacturer's in-
structions (Thermo Fisher Scientiﬁc, #11668019).
2.4. Lentiviral production, infection, and gene knockdown
Lentivirus-mediated knockdown was performed as described
previously [24].
2.5. RNA isolation, cDNA synthesis, and qPCR
RNA isolation, synthesis of cDNA, and real-time qPCR was per-
formed as described previously [25]. Sequences of qPCR primers are
provided in Supplementary Table T1.
2.6. Western blot analysis
Western blot was performed as described previously [23]. Cell
lysis was achieved using 1 sample buffer (62.5 mM Tris-HCl [pH
6.8], 10% glycerol, 1% b-mercaptoethanol, 2% SDS, 0.01% bromo-
phenol blue) unless otherwise stated. Band quantitation was per-
formed using Image Studio v3.1 (LI-COR Biosciences).
2.7. Immunocytochemistry
EGFP-LC3-expressing cells were grown in 600 mg/mL G418
(Sigma Aldrich, A1720) for 10 d, and then stable clones were sorted
using FACS Aria (BD Biosciences). The mixed population was used
for transient expression of mRFP-hTERT. Immunocytochemistry
and western blotting were performed 48 h after transfection using
a previously reported protocol [23].
2.8. MTT assay
An MTT assay was performed as described previously [26].
2.9. Statistical analysis
GraphPad Prism 6 was used for statistical analysis. The data are
presented asmean± SD, and Student's t-test was used to determine
the level of signiﬁcance. A p-value <0.05 was considered statisti-
cally signiﬁcant.
3. Results
3.1. TERT inhibits the kinase activity of mTORC1
Previous studies have reported that TERT binds to mTORC1 and
that this binding decreases upon rapamycin-mediated inhibition of
mTORC1 [27,28]. This observation indicates that TERT preferentially
binds to the activated form ofmTORC1; however, the signiﬁcance of
preferential binding of TERT to activated mTORC1 in cellular
physiology has not been demonstrated. Since the gain of function of
both TERT and mTORC1 is observed in many cancers [13,17]
(Supplementary Fig. S1AeD), we hypothesized that reactivation
of telomerase in human tumorigenesis may serve as a protective
mechanism to ﬁne tune the kinase activity of mTOR in order to
promote cancer cell survival. To determine the nature of mTORC1
regulation by TERT, we ﬁrst measured TERT-mediated alteration of
the kinase activity of mTORC1, which phosphorylates p70S6K at
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kinase activity of mTORC1 as determined by decreased phosphor-
ylation of the mTORC1 target p70S6K (p-T389) (Fig. 1A). Similarly,
TERT knockdown resulted in increased phosphorylation of p70S6K
(p-T389) (Fig. 1B). We next determined whether TERT-mediated
inhibition of mTORC1 translates into activation of autophagy, as
mTORC1 is a strong negative regulator of autophagy [3]. Ectopic
expression of hTERT increased the activated form of LC3, LC3-II,
which is considered a marker of induction of autophagy [20], while
TERT knockdown decreased LC-II (Fig. 1A and B). We also conﬁrmed
hTERT-mediated suppression of mTORC1 and induction of auto-
phagy in HepG2 and U2OS cells (Fig. 1C and D). Taken together,
these results indicate that hTERT mediates inhibition of mTORC1
activity, resulting in the activation of autophagy and suggest that
hTERT controls the hyperactivation of mTORC1 in cells.
3.2. TERT induces autophagy by decreasing kinase activity of
mTORC1
The mTORC1 protein complex serves as a central negative
regulator of autophagy [29]. Amino acids, growth factors, ATP, and
oxygen levels activate mTORC1 activity and are known to be strong
suppressors of autophagy [30]. Induction of autophagy has been
observed as a direct result of mTORC1 inhibition. Post-translational
modiﬁcation of LC3-I to LC3-II is considered to be a reliable marker
for the induction of autophagy [20]. Since TERT inhibited mTORC1
activity (Fig. 1AeD), we expect that the immediate effect of this
inhibition will be induction of autophagy. To clearly establish the
contribution of TERT to the activation of autophagy under basalFig. 1. hTERT decreases the kinase activity of mTORC1 under basal condition. (A) HEK 293T
30 h after transfection, cells were lysed, and immunoblotting was performed using the indic
cells. Cells were used for qPCR and western blot (WB) 48 h and 72 h post-infection, respectiv
indicated antibodies (shC ¼ empty vector pLKO.1). (C, D) HepG2 and U2OS cells were procconditions, we examined the effects of the overexpression of hTERT
in 293Tcells. Indeed, overexpression of hTERT increased the level of
LC3-II, and these levels were further increased upon treatment of
cells with autophagosome-lysosome fusion inhibitors such as
baﬁlomycin and chloroquine (Fig. 2A and B). Under the same con-
ditions, the phosphorylation of p70S6K (T389) was decreased,
indicating suppression of mTORC1 activity (Fig. 2A). To further
demonstrate the role of hTERT in the activation of autophagy, we
generated a 293T cell line that stably expresses EGFP-LC3. Upon
mRFP-hTERT expression, levels of both EGFP-LC3-II and LC3-II were
increased as detected by western blotting (Fig. 2C). Consistently,
the number of EGFP-LC3-stained punctawere increased, suggesting
that hTERT mediated autophagy activation (Fig. 2D). To determine
whether TERT also induces autophagy in primary cells, we
measured LC3-II levels in Tert-wild type (Tert-WT) and Tert-trans-
genic (Tert-Tg) MEFs. Tert-Tg MEFs displayed increased LC3-II
compared to Tert WT MEFs, and these levels were further
increased by treatment with chloroquine (Supplementary Fig. S2A
and Fig. 2E). The observed TERT-mediated increase in LC3-II was a
due to post-translational effects, because the Lc3b transcript was
not affected by Tert levels (Supplementary Fig. S2A and B). Collec-
tively, these data indicate that TERT induces basal autophagy by
suppressing the kinase activity of mTORC1.
3.3. TERT induces autophagy under amino acid starvation
conditions
Tumor cells encounter harsh microenvironment conditions, and
autophagy is induced due to the limited nutrient availability, which/17 cells were transfected with Flag-tagged hTERT expression plasmid. Approximately
ated antibodies. (B) Lentivirus-mediated knockdown of TERT was achieved in HEK 293T
ely. Fresh media was added 12 h before lysis, and immunoblot was performed using the
essed as described in (A).
Fig. 2. TERT induces basal autophagy. (A) 293T cells were treated with indicated drugs (50 mM for 4 h), lysed in 1 sample buffer, and examined by immunoblotting using the
indicated antibodies. (B) HEK293T cells transfected with TERT expression plasmid were grown under basal condition for 30 h, treated with baﬁlomycin (20 nM) or chloroquine
(50 mM) for 4 h, and then lysed in RIPA buffer. The indicated antibodies were used for immunoblotting. (C, D) The EGFP-LC3-expressing stable cell line was transfected with mRFP-
hTERT. Approximately 48 h after transfection, LC3-II and EGF-LC3-II were observed by immunoblotting, and GFP-LC3-II-positive puncta were observed using ﬂuorescence mi-
croscopy (Nikon TE2000). The scale bar represents 20 mm. Arrow heads show EGFP-LC3 puncta. (E) Passage 2 of Tert wild-type and transgenic MEFs were treated with chloroquine
(CQ; 50 mM for 3 h) or left untreated (NT), and immunoblotting was performed using the indicated antibodies as described in (A). (Symbol ‘#’ indicates embryo number).
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acids, from growing cells in culture [31e34]. In the absence of
extracellular nutrients, autophagy is rapidly induced, resulting in
degradation of intracellular components to supply substrates for
maintenance of cell survival [35].
To examine TERT-mediated regulation of autophagy upon
nutrient deﬁciency, we measured LC3-II levels in Tert-WT and Tert-
Tg MEFs grown in EBSS with or without chloroquine. Tert-Tg MEFs
grown in only EBSS displayed increased LC3-II levels that were
further increased in the presence of chloroquine, suggesting that
TERT induces autophagy under nutrient-deprived conditions as
well (Fig. 3A). Similarly, ectopic expression of hTERT in 293T cells
resulted in rapid formation and elimination of LC3-II compared to
that in control cells, suggesting an acceleration of autophagy ﬂux by
hTERT upon nutrient deﬁciency (Fig. 3B and C). Taken together,
these results demonstrate that TERT induces autophagy under both
basal and amino acid-deprived conditions.3.4. Tert KO MEFs exhibit impaired autophagy ﬂux and decreased
viability under nutrient-deﬁcient conditions
Next, we sought to elucidate the functional signiﬁcance of TERT-
mediated suppression of mTORC1 activity and activation of auto-
phagy. For this purpose, we used MEFs that lack Tert expression
(Tert knockout MEFs [Tert-KO MEFs]). Consistent with the role of
TERT in the activation of autophagy, TERT-deﬁcient MEFs displayed
increased accumulation of LC3-II (Fig. 4A). Upon chloroquine
treatment, both Tert-WT and Tert-KO MEFs displayed comparablelevels of LC3-II, suggesting a defective autophagy ﬂux in KO MEFs
(Fig. 4A and B). This result demonstrates an important role for TERT
in the proper execution of autophagy ﬂux. When these cells that
lack the ability to properly execute autophagy were subjected to
nutrient deprivation, the cells displayed increased susceptibility to
cell death compared to control cells at each time-point (Fig. 4C).
Based on this result, we concluded that the functional role of TERT-
mediated modulation of mTORC1 activity is to provide nutrient
buffering to the cells in cases of nutrient deﬁciency via activation of
autophagy.
Collectively, our study demonstrated that the functional role of
the gain of TERT activity is to ﬁne tune the kinase activity of
mTORC1 to its optimal level so that autophagy can be activated to
provide essential nutrients for cells, such as cancer cells, that grow
in a metabolically challenged tumor environment.4. Discussion
The primary function of autophagy is tomaintain quality control
for proteins and organelles in order to enhance cell survival under
conditions of nutrient scarcity [36]. In addition to its particular role
in adaptation to nutrient deprivation and growth factor depletion,
autophagy protects organisms against diverse pathologies,
including neurodegeneration, aging, and heart disease [37]. Evi-
dence suggests that TERT contributes to cellular protection against
etoposide, a dsDNA-damaging agent [38]. Previous work has
established the localization of TERT to the mTORC1 [39]. Thus, the
aims of our study were to uncover the signiﬁcance of the
Fig. 3. TERT induces autophagy under amino acid starvation conditions. (A) MEFs of passage 3 were treated with chloroquine-containing EBSS media for the indicated time period.
Immunoblotting was performed using the indicated antibodies. (B, C) TERT-transfected cells were incubated under conditions of amino acid starvation for the indicated times
(0e4 h) and then lysed in 1 sample buffer. Immunoblotting was performed using the indicated antibodies. Band quantitation was performed using Image Studio.
Fig. 4. Tert-KO MEFs have attenuated autophagy ﬂux and decreased viability. (A, B) Passage 3 Tert-WT and -KO MEFs were grown in 6-cm dishes. Cells were treated with chlo-
roquine (CQ; 50 mM for 3 h) or left untreated (NT). Immunoblotting was performed using the indicated antibodies. Band quantitation was performed using Image Studio. LC3-II/b-
actin ratios were used to generate the box plot. (C) Passage 3 Tert-WT and Tert-KO MEFs were seeded in 96-well plates and grown under conditions of amino acid starvation in
serum-free EBSS for the indicated time periods. Cell viability was calculated using the MTT survival assay (n ¼ 8). Data are expressed as the means ± standard deviation (SD).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ‘ns’ stands for non-signiﬁcant p-value.
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logical phenomenon involved in this process. Our results demon-
strate that TERT suppresses the kinase activity of mTORC1, prevents
lethal hyperactivation of mTORC1, and activates the autophagy
pathway. TERT-mediated activation of autophagy, in return, pro-
vides essential micromolecules to cells to support their survival in
metabolically challenged conditions.
Cancer cells beneﬁt from optimally activated mTORC1 due to
advantages conferred by scavenged nutrients in the challenging
growth microenvironment; however, hyperactivation of mTORC1 islethal to cancer cells due to the consequent promotion of ER stress
as increased protein synthesis can overwhelm the protein folding
capacity of the ER [14]. High-energy diets and chronic mTORC1
activation are associated with obesity, hepatosteatosis, and insulin
resistance that results in pronounced risk for hepatocellular carci-
noma (HCC) [40]. Pharmacological inhibition of mTORC1 exacer-
bate pathological HCC [12]. Similarly genetic mutations that result
in loss of mTORC1 activity enhance hepatocarcinogenesis [12]. Two
of the strategies to inhibit mTORC1 exacerbate pathologies, sug-
gesting that a regulator for mTORC1 activity is necessary instead of
M. Ali et al. / Biochemical and Biophysical Research Communications 478 (2016) 1198e1204 1203using strong activators or suppressors [12]. Therefore, the ﬁndings
of TERT-mediated inhibition of mTORC1 (Figs. 1 and 2) [21] and
detachment of TERT from the complex upon rapamycin treatment
[27,28] indicate that TERT plays a regulatory role in the ﬁne tuning
of mTORC1 activity to the optimal level that favors cancer cell
survival. Though tumors alter their metabolism to predominantly
use glucose as explained by conventional Warburg's effect [41],
cancer cells still require amino acids as building blocks to support
proliferation [42]. Our model suggests that cancer cells particularly
favor gain of TERT function so that these building blocks can be
generated by TERT-induced autophagy. Further studies are required
to determine the extent of cancer cell addiction to TERT-induced
autophagy as well as to examine the possibility of blocking this
pathway as a therapeutic strategy.
These studies provide the ﬁrst experimental evidence demon-
strating the role of TERT as a positive regulator of autophagy under
both basal and amino acid-deﬁcient conditions. At the molecular
level, mTORC1 inhibition causes autophagy induction by TERT in
order to provide a protective effect to cells under conditions of
nutrient deﬁciency. Since the gain of mTORC1 and TERT functions
has been observed in many cancers [13,17] (Supplementary
Fig. S1AeD), we propose a model in which the increased nutri-
ents required to support enhanced proliferation and biosynthetic
pathways driven by optimally activated mTORC1 signaling is pro-
vided by TERT-induced autophagy. Pharmacological inhibition of
TERT has been proven to limit growth of cancer cells [43,44]. Thus,
inhibition of TERT activity represents a therapeutic opportunity to
target cancer cells in order to minimize optimal activation of
mTORC1 signaling and nutrient scavenging by blocking autophagy.
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